CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis1
- 1 October 1999
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 99 (2) , 218-223
- https://doi.org/10.1016/s0165-5728(99)00120-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelinationAnnals of Neurology, 1998
- Proinflammatory cytokines regulate antigen-independent T-cell Activation by two separate calcium-signaling pathways in multiple sclerosis patientsAnnals of Neurology, 1998
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosisJournal of Neuroimmunology, 1996
- Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridizationCytokine, 1993
- Interleukin-6 is elevated in plasma in multiple sclerosisJournal of Neuroimmunology, 1991
- Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitisEuropean Journal of Immunology, 1990
- Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients.The Journal of Experimental Medicine, 1988
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983